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A B S T R A C T
Aims: The altered gut-brain interaction can be in the background of functional gastrointestinal (GI) disorders. In
the GI tract, the slow-wave myoelectric signals can be detected by electromyography (EMG). The aims of our
study were to follow up the stress induced alteration in the GI tract by smooth muscle EMG in wakeful rats.
Main methods: The GI tract myoelectric activity of male rats was measured by an electrode pair under the
abdominal skin, the responses were detected and analyzed by a software using fast Fourier transformation.
Animals were immobilized and treated with either diazepam or haloperidol. The plasma corticosterone level was
determined by ELISA kit, the levels of drugs were measured by HPLC, while the direct GI eﬀects of the com-
pounds were tested in an organ bath.
Key ﬁndings: Signiﬁcant correlation (r2= 0.52) was found between the immobilization induced increase in the
EMG spectra of the GI tract segments and the increase in corticosterone plasma levels. The stress-reducing eﬀects
of diazepam and haloperidol were also detectable by smooth muscle EMG in the GI tract. No direct smooth
muscle actions of the drugs were found in organ bath studies.
Signiﬁcance: The smooth muscle EMG instrument can measure the level of acute stress and is applicable for the
investigation of central nervous system aﬀecting drugs through the GI tract in awake rats. This is the ﬁrst tool to
measure the stress response via the GI tract reactions. The technique may open a new perspective in the diagnosis
and therapy of psychosomatic disorders.
1. Introduction
The gut-brain axis creates a two-way communication network cre-
ated by the complex system of the enteric nervous system (ENS), cer-
ebral nerves and the humoral system. The ENS can aﬀect all intestinal
functions, including motility and all gastrointestinal (GI) motor func-
tions, absorption and secretion, the regulation of food intake [1].
Functional GI malfunctions can be the consequences of dysregulation in
the gut–brain axis. The altered gut-brain interaction can be in the
background of functional GI disorders and other motility diseases, such
as gastroesophageal reﬂux disease and irritable bowel syndrome. The
investigation of the gut-brain axis and the enteric plexus activity helps
to promote the understanding of GI diseases and the therapies for GI
disorders and stress-induced GI malfunctions [2–4].
Patients with anxiety and depressive disorders have a higher in-
cidence of functional GI disorders that are frequently unrecognized [5].
One of the major reasons for this low recognition is the lack of a reliable
method to detect the GI tract motility in psychiatric disorders. Such a
method would be useful to help the diagnosis of given mental disorders
and to assess the eﬃcacy of the therapies both for mental and GI pro-
blems [6]. There is a need for the development of an in vivo technique
which allows us to determine the strength of muscle contraction and the
possible electrical abnormalities in motility disorders related to psy-
chiatric problems [7].
Motion artifacts are major obstacles to the various electromyo-
graphic examinations in wakeful subjects. Studies have demonstrated
that the results of electroencephalographic (EEG) records can be mod-
iﬁed by muscle work during the record because the frequencies of the
brain and myogenic activity are overlapping. The electromyographic
(EMG) signals can be eliminated by computerized screening from EEG
records [8]. The skeletal muscle induced motion artifacts have higher
amplitude compared to the basal activity, which may cause large dis-
tortion in the measurement. Therefore motion artifacts have to be ﬁl-
tered out, however, in the case of overlapping frequencies, ﬁltering can
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result in signiﬁcant data loss [9,10].
In the GI tract, slow-wave signals can be detected by EMG. In an-
esthetized rat, we successfully identiﬁed the characteristic slow-wave
signals and frequency values for the stomach, ileum, cecum and uterus,
which were 3–5, 20–25, 1–3 and 1–2.5 cycles per minute (cpm), re-
spectively. Although the pregnant uterine and cecal smooth muscle
signals are overlapping, the myometrial activity is predominant in late
pregnancy, while cecal signals are much more robust in nonpregnant
animals. In pregnant animals the diﬀerent pharmacological relativity of
the uterus and the large intestine was also clearly detectable by EMG
[11,12].
Based on these results, we hypothesized that our smooth muscle
EMG method - accomplished with a digital cutter for removing motion
artifacts - can be applicable in wakeful rats under normal and stress
conditions. The aims of our study were to follow up the stress condition
induced alteration in the GI tract and to measure the eﬀects of central
nervous depressants by smooth muscle EMG in wakeful rats.
2. Materials and methods
2.1. Housing and handling of the animals
The study was conducted using male Sprague-Dawley rats
(10–14weeks old, body weight: 260–350 g). The animals were treated
in accordance with the European Communities Council Directives (86/
609/ECC) and the Hungarian Act for the Protection of Animals in
Research (Article 32 of Act XXVIII). All experiments involving animal
subjects were carried out with the approval of the Hungarian Ethical
Committee for Animal Research (registration number: IV/3796/2015).
Sprague-Dawley rats (Charles-River Laboratories, Budapest,
Hungary) were housed at 22 ± 3 °C and a relative humidity of
30–70%, under a 12 h light/12 h dark cycle. Standard rodent pellet food
(Charles-River Laboratories, Budapest, Hungary) and tap water were
provided ad libitum.
2.2. Electromyographic measurements, drug treatments and immobilization
Male rats were anesthetized with isoﬂurane inhalation, then a bi-
polar disk electrode pair (SEN-15-2; MDE GmbH, Walldorf, Germany)
was ﬁxed subcutaneously 1 cm right from the midline above the gas-
trointestinal tract (the distance between the two electrodes was
20mm). The connecting cable of the sensor to the swivel was led
subcutaneously and the terminal was led out through the skin of the
neck. After the placement of the sensor, the abdominal and cervical
incision surfaces were closed by surgical sutures and staples, respec-
tively.
The basal activity was detected the day after the placement of the
sensors. Food and water were withdrawn 2 h before and during the
detection. The animals were placed one by one in cages with high-
pitched walls, with a transparent wall at the front side. The animals
were not restricted in their movements for 30min while recording basal
GI tract activity (control). Then the rats were anesthetized with 3.5%
isoﬂurane inhalation and placed and ﬁxed onto a glass plate by strong
sticky belts. The rats were laid on the abdomen and were not able to
move or turn around. After full awakening (3–5min), the GI activity
was recorded again for 30min under this stress condition. When dia-
zepam (5mg kg−1) or haloperidol (1 mg kg−1) was administered in-
traperitoneally for the given groups of rats, the treatments were done
after recording the basal activity. Then 30-min recording was carried
out for each drug to determine their actions before and during stress
condition.
The myoelectric signals were recorded and analyzed by an on-line
computer system by the S.P.E.L. Advanced ISOSYS Data Acquisition
System (MDE GmbH, Walldorf, Germany). Electromyographic (EMG)
signals were ampliﬁed by using a custom-made ampliﬁer. All analogue
signals were ﬁltered with a ﬁrst-order bandpass Bessel-type ﬁlter with a
frequency of 0–30 cycles per minute (cpm) and were converted to di-
gital signals at a sample rate of 2 Hz. The recorded signals were ana-
lyzed by fast Fourier transformation (FFT). The FFT of 30-min periods
were evaluated. The frequency of the electric activity was characterized
by cpm, and the magnitude of the activity was described as power
spectrum density (PsD). When more than one peak was found in the
spectrum, the highest peak was considered as characteristic for the
given GI tract segment. During the evaluation, the EMG spectrum of
basal activity was compared to the activities after drug treatment or
during stress period. The stress-induced alterations were expressed as
percentage of the spontaneous activity. The PsDmax values were com-
pared statistically (one-way ANOVA) by using the computer program
Prism 5.0. (GraphPad Software, USA).
To remove the motion artifacts, a digital cutter was built into the
software. The edge values of the limiter were set by the motion artifact-
free sections of the records. Thereby, we were able to cut the artifact
signals by their obviously high outlier amplitude.
2.3. Collection of plasma and organ samples
At the end of each period of 30min, samples of 0.5 ml blood were
collected from the tail veins into 1ml tubes containing K3EDTA
(0.6mg/tube) and centrifuged (1700×g, 10min, 4 °C) to separate
plasma. The plasma samples were stored at−20 °C until hormone assay
and HPLC analysis. The organ samples for haloperidol determination
were collected after termination by CO2 inhalation. Brain, lung and
liver tissue samples were homogenized in 0.01M KH2PO4
(pH=4.3):methanol= 75:25 mixture (1:4w/v) with a tissue blender.
Tissue homogenates were stored at −70 °C until HPLC analysis.
2.4. Plasma corticosterone analysis
The plasma concentration of corticosterone was measured by en-
zyme-linked immunosorbent assay (ELISA). A Mouse/Rat
Corticosterone ELISA (BioVendor, Bio-Kasztel Ltd., Hungary) kit was
used for the quantiﬁcation of corticosterone, according to the manu-
facturers' manual.
2.5. HPLC analysis
2.5.1. Chemicals and reagents
HPLC-grade acetonitrile, methanol, isopropyl alcohol and ammo-
nium hydroxide were purchased from VWR International Ltd.
(Debrecen, Hungary). Potassium dihydrogen phosphate and glycine
were of analytical grade and purchased from Sigma-Aldrich (Budapest,
Hungary). The water was puriﬁed and deionized by Milli-Q system
(Millipore, Milford, MA, USA). Haloperidol (5 mgml−1 haloperidol,
Gedeon Richter Plc., Hungary) and Seduxen (5mgml−1 diazepam,
Gedeon Richter Plc., Hungary) injections were applied to treat the an-
imals and as standards.
2.5.2. HPLC system and conditions
The HPLC apparatus consisted of a Shimadzu system (Shimadzu
Corporation, Kyoto, Japan) equipped with a solvent delivery system
(LC-20 CE), DGU-20A3 on-line degasser, SIL 20A HT auto injector, CTO-
20A column oven, SPD-M20A photodiode-array detector and CBM-20A
system controller. The system control and data acquisition were per-
formed by Shimadzu “LC solution” software (Shimadzu Corporation,
Kyoto, Japan).
The chromatographic separations were performed on a Kromasil
Eternity C18 (5 μm, 150mm×4.6mm) analytical column, protected
by a 5 μm guard column. The column temperature was kept constant at
35 °C. Separations were performed in isocratic mode. The mobile phase
used for the separation consisted of acetonitrile:water:isopropyl alco-
hol:ammonium hydroxide=40:50:10:0,025 (v/v/v/v) pumped at a
ﬂow rate of 1mlmin−1. The mobile phase was ﬁltered by a Millipore
K.F. Szűcs et al. Life Sciences 205 (2018) 1–8
2
vacuum ﬁltration system equipped with a 0.45 μm pore size ﬁlter and
degassed by ultra-sonication. The detection wavelength was 245 nm.
2.5.3. Preparation of standard solutions, calibration samples
Haloperidol injection and diazepam injection were diluted with
normal saline to the concentration of 0.25mgml−1, and then further
diluted with mobile phase to obtain a series of working standard so-
lutions. Stock solutions were stored at −20 °C and working solutions
were kept refrigerated at 2–6 °C. The working solutions were used to
prepare 6 calibration samples in blank serum (0.01, 0.05, 0.1, 0.5, 1
and 1.5 μgml−1) for haloperidol and diazepam. The calibration sam-
ples of haloperidol for brain, lung and liver tissues were prepared at the
following concentrations: 0.05, 0.1, 0.5, 1, 2.5 and 5 μg g−1.
2.5.4. Sample preparation
An aliquot of plasma or tissue homogenate sample (200 μl) was
combined with 20 μl of 50 μgml−1 internal standard solution and
100 μl 1 M glycine buﬀer (pH=10.5), then 1.5ml acetonitrile was
added. The mixture was vortexed for 1.5 min and centrifuged at
12,000 rpm for 10min at 4 °C. The supernatant was transferred to an-
other clean glass tube and evaporated to dryness under a stream of
nitrogen at 40 °C. The residue was reconstituted in 100 μl mobile phase
and vortex-mixed for 10 s; a volume of 20 μl solution was injected for
analysis.
2.5.5. Calibration curve
Six-point calibration curves, prepared in triplicate, showed good
linearity (R2= 0.9450 ± 0.010 and R2=0.9980 ± 0.008) for dia-
zepam and haloperidol, respectively. The recovery of diazepam from
plasma samples was 78.35 ± 3.68%. The recovery of haloperidol from
plasma and organ samples was 96.4 ± 4.33% and 98.7 ± 3.02%, re-
spectively. The limits of quantiﬁcation were 10 and 5 ngml−1 for dia-
zepam and haloperidol, respectively. The limits of detection were 3 and
1 ngml−1 for diazepam and haloperidol, respectively.
2.6. Contractility studies in isolated organ bath
Before measurement, rats were fasting for 24 h. The animals were
terminated by CO2 inhalation. The stomach, ileum and cecum were
dissected, rinsed with Tyrode solution (composition in mM: 137 NaCl, 3
KCl, 1 CaCl2, 1 MgCl2, 12 NaHCO3, 0.4 NaH2PO4, 6 glucose, pH 7.4)
and cleaned from fat. Strips from the stomach were prepared as
Fig. 1. The primary myoelectric signal of the gastrointestinal tract in rat with outlier peaks of motion artifact (A) was cut by the software in-built digital cutter to
remove the motion artifacts (B). The speciﬁc spectra were gained by fast Fourier transformation (FFT). The red curve represents the FFT spectrum of the primary
spectrum with motion artifacts, while the blue curve shows the spectrum after the digital cut. The cycle per minute (cpm) frequencies of the peak values remained the
same after modiﬁcation, but with lower power spectrum density maximum values (C). (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
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described earlier [13]. The ileum and the cecum were cut into 5-mm-
long muscle rings. The smooth muscle samples were mounted vertically
in an organ bath containing 10ml, 37 °C Tyrode buﬀer and carbogen
(95% O2+ 5% CO2) was bubbled through it. The initial tension of the
tissues was set to 1.5 g. The samples were incubated for 60min, the
buﬀer solution was changed in every 15min. After the incubation
period, the control contractions of smooth muscle were evoked by KCl
(25mM) and a cumulative dose-response curve of 10−4–10−9 M dia-
zepam or haloperidol was obtained. The activity of gastric strips, ileal
and cecal rings was measured with a gauge transducer (SG-02, MDE
GmbH, Walldorf, Germany) and recorded with a SPEL Advanced
ISOSYS Data Acquisition System (MDE GmbH, Walldorf, Germany). The
haloperidol or diazepam eﬀects were characterized by the percentage of
the area under curves (AUC) values of recorded contractions before and
after adding them into the organ bath. The analyzed periods were 5min
both for the control and the drug-altered contractions.
3. Results
The myoelectric activity of the GI tract was detected in awake rats.
The motion artifacts had approximately 4-fold higher signals on the
primary record as compared with the GI tract activity. The motion ar-
tifact was separated from the basal electric activity of the GI smooth
muscle by the cutter built into the software. With this modiﬁcation, the
motion artifact-induced peaks were cut in the primary curves (Fig. 1A,
B). When the modiﬁed EMG curves were transformed by FFT, the
PsDmax values on the modiﬁed spectra were reduced, but the cpm fre-
quencies of the PsDmax values remained in the same range (Fig. 1C).
The digital cut reduced the motion artifact elevated PsDmax values
to the range of values in anesthetized rats, but did not further reduce
the values detected in anesthetized rats (Fig. 2).
Immobilization stress signiﬁcantly increased the plasma level of
corticosterone. The rate of increase was approximately 3-fold as com-
pared with the resting value (resting value: 75.4 ngml−1, stress value:
214.5 ngml−1) (Fig. 3A). In parallel, the PsDmax values in the whole GI
tract were elevated 1.5-2-fold during immobilization. The greatest in-
crease was found in the gastric values, although the increase in the
gastric PsDmax values was not signiﬁcantly higher than the increase in
the small or large intestine values (Fig. 3B).
Diazepam treatment reduced the resting EMG activity by 40–60%,
while the stress-induced PsDmax values were set back to the resting
level, reaching around 100% in all the three GI tract sections. In the
large intestine, immobilization stress did not induce a signiﬁcant in-
crease in the presence of diazepam (Fig. 4A). Haloperidol treatment
reduced the resting EMG activity by 40%, but immobilization stress was
not able to induce signiﬁcant elevation in the myoelectric activity of the
Fig. 2. Changes of power spectrum density (PsDmax) values in stomach (A), small intestine (B) and large intestine (C) in rats (n=20). The motion artifact in the
conscious animal group led to high PsDmax values, but these outliers were removed with the digital cutter. The application of the digital cutter did not modify
signiﬁcantly the motion artifact-free myoelectric signals from the anesthetized rats, but reduced the PsDmax values of conscious rats to the anesthetized level after the
cut. (ns: not signiﬁcant; p < 0.01**).
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whole GI tract (Fig. 4B).
Both diazepam and haloperidol treatments reduced the plasma
corticosterone levels during the resting period by approximately 30%,
however, these alterations were not signiﬁcant. Only haloperidol was
able to blot out the stress hormone inducing eﬀect of immobilization
(Fig. 5).
The plasma level of diazepam was 0.42 μgml−1 at the end of the
resting period (30min after drug administration), and its level was
reduced to 0.13 μgml−1 at the end of the stress period (60min after
drug administration). Haloperidol was not detectable in the plasma
even at the end of the resting period, but it was found in the brain, liver
and lung in a concentration of 0.30, 1.91 and 2.23 μg g−1, respectively.
At the end of the stress period, the levels of haloperidol were still
considerable in these organs (brain: 0.16 μg g−1, liver: 1.33 μg g−1,
lung: 0.96 μg g−1). After statistical analysis, only the pulmonary level of
haloperidol at the end of the stress period was signiﬁcantly lower as
compared with the end of the resting period (Fig. 6).
Signiﬁcant correlation was found between the drug induced change
in the PsDmax values of the stomach, small intestine or large intestine
and the change in corticosterone plasma levels. The levels of correla-
tions were the same in all the three GI tract segments (Fig. 7).
Neither diazepam nor haloperidol elicited any signiﬁcant relaxing
eﬀect on gastric strip, ileal or cecal rings in isolated organ studies
(Fig. 8).
Fig. 3. Immobilization stress induced a signiﬁcant increase in the plasma cor-
ticosterone level of rat (n=20) as compared with the resting period (***:
p < 0.001) (A). The stress condition also raised the power spectrum density
(PsDmax) values of the FFT spectra from the stomach, small intestine and large
intestine as compared with the resting period. (B).
Fig. 4. Changes in power spectrum density maximum (PsDmax) values after
diazepam (A) or haloperidol (B) treatments in conscious rats (n=15 for each
group) under immobilization-induced stress. The values are expressed as the
percentage of the resting values without drug treatment. Both diazepam and
haloperidol reduced the myoelectric activities of the gastrointestinal smooth
muscles. They reduced the PsDmax values during the stress-free period, how-
ever, only haloperidol was able to inhibit the increase in the PsDmax value
during immobilization stress. (ns: not signiﬁcant; p < 0.01**; p < 0.001***).
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4. Discussion
The non-invasive and reliable measurement of stress condition by
physiological parameters is still an unsolved clinical problem. Although
the relationships between stress condition and organ systems like car-
diovascular, dermal or GI systems are obvious, the level of stress is
mostly appraised by psychological tests [14]. A new technique and
instrument measuring both psychological and physiological parameters
have been reported for stress evaluation. Among the physiological
parameters, this instrument detects cardiovascular and dermal re-
sponses [15], however, the GI parameters are not involved in the
analysis. Although the in vivo GI motility can be assessed by the mea-
surement of gastric content [16] or by the detection of a colored marker
in the intestine [17], these methods evaluate the GI responses after the
termination of the experimental animals.
The consequences of the function of the brain-gut axis include the
stress induced alterations in the GI tract motility, which may lead to
inﬂammatory bowel disease, peptic ulcer and many other GI tract dis-
orders [18]. Acute stress response enhances the motility in the GI tract,
which is controlled by peripheral neuropeptides and corticosterone-
releasing hormone [19]. Previously we developed an in vivo smooth
muscle EMG method to measure the GI tract (stomach, small and large
intestine) myoelectric activity, which showed very strong correlation
with the mechanical contractions in anesthetized rats [11]. We hy-
pothesized that this method can be applicable to awake rats and to
measuring the correlation between GI tract motility and stress condi-
tion.
Awake EMG measurements are always disturbed by motion arti-
facts, especially in experimental animals where the movements cannot
be reduced by self-control. Therefore, our ﬁrst task was to identify the
EMG signals of motion artifacts and then develop a digital cutter to
remove them from the record without signiﬁcant loss of smooth muscle
data. The motion artifacts had much bigger EMG signals than the
smooth muscle did, thus their identiﬁcation and removal was an easy
task by the newly developed digital cutter. The goodness of cut was
proved by the FFT spectrum analysis, in which the characteristic peaks
remained at the same frequency, only their PsDmax values were re-
duced, which could be anticipated before cut. After cut, the smooth
muscle EMG record showed basal activity like in anesthetized animals,
where the motion artifact is a nonsigniﬁcant factor. These results sug-
gest that we have successfully kept the smooth muscle signals with the
eﬀective removal of motion artifact.
Acute immobilization, which increases the plasma corticosterone
level, is an accepted stress method in rats [20]. Immobilization can
increase the stress factors within quite a short period of time,
30–60min can be enough for the signiﬁcant elevation of stress hormone
Fig. 5. Alterations of plasma corticosterone levels by drug treatments (red
columns: diazepam, blue columns: haloperidol) and immobilization stress in
rats (n=15 for each group). The hormone level was elevated signiﬁcantly by
stress compared to the control level. Diazepam (5mg kg−1) or haloperidol
(1 mg kg−1) treatment alone reduced the plasma corticosterone values, al-
though the alterations were not signiﬁcant. Only haloperidol was able to inhibit
the increase in the plasma corticosterone level during immobilization stress. (D.
diazepam; H: haloperidol; ns: not signiﬁcant;*: p < 0.05; **; p < 0.01). (For
interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 6. Plasma levels of diazepam (red columns) and
organ levels of haloperidol (blue columns) after 30min
(end of resting period) and 60min (end of stress period)
of intraperitoneal administration (5mg kg−1 for dia-
zepam, 1mg kg−1 for haloperidol) in rats (n=15 for
each group). The drug levels were determined by the
HPLC method. (D: diazepam; H: haloperidol; ns: not sig-
niﬁcant; *: p < 0.05). (For interpretation of the refer-
ences to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
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levels in rodents [21,22]. Considering this fact, we applied im-
mobilization to our rats for 30min, which period is also suitable for the
detection of GI tract myoelectric activity. Both corticosterone and
PsDmax values were increased during the immobilization, and the cor-
relation found between the two parameters indicates that the severity
of acute stress can be predicted by the detection of smooth muscle EMG
in awake rats. This correlation was reinforced by the results gained
after treatment with central nervous system depressants.
Diazepam is a well-known anxiolytic agent, which elicits a moderate
stress reducing eﬀect in rats [23]. Haloperidol is a strong antipsychotic,
which can cease the whole stress response, although it can induce
oxidative stress in the brain but only in the case of chronic treatment
[24]. However, in our experiments the animals were terminated after
60min of single drug treatment, therefore the oxidative stress-inducing
eﬀect of haloperidol could not develop. The plasma levels of both
diazepam and haloperidol were checked 30min (end of resting period)
and 60min (end of stress period) after their administration. The mea-
surement of plasma levels was important to justify the presence of ef-
fective concentrations during our experiments. In the case of diazepam,
the lowest plasma level was around 0.1 μgml−1 at the end of the ex-
periments, which provides suﬃcient anxiolytic action in rats [25].
Haloperidol has special pharmacokinetics with a fast distribution into
diﬀerent organs, thus the concentration of haloperidol in these organs
can be much higher than its plasma concentration after 1 h of par-
enteral administration [26]. In our experiments, the haloperidol plasma
level was under the limit of our detection even after 30min, but
signiﬁcant amounts of drug were found in the brain, liver and lung.
Since around 0.1 μg g−1 concentration of haloperidol is considered to
have therapeutic action in rats [27], the 0.16 μg g−1 concentration that
was found after 1 h in the brain of our rats seems to be satisfactory to
provide the required neuroleptic eﬀect.
While haloperidol blocked the rise of corticosterone during acute
stress, diazepam was only able to reduce the increase in the stress
hormone level. This diﬀerence between the eﬀects of these two types of
drug was clearly detectable in the smooth muscle EMG response of the
GI tract, especially in the gastric and the small intestine PsDmax values.
The isolated organ bath studies proved that neither diazepam nor ha-
loperidol had a direct smooth muscle relaxing eﬀect on the GI tract
smooth muscles, therefore the responses found in awake rats originated
from their central nervous system eﬀects, possibly mediated through
the brain-gut axis.
5. Conclusion
Based on these results, it can be concluded that our smooth muscle
EMG instrument after FFT analysis can measure the level of acute stress
in awake rats, which shows correlation with the stress hormone plasma
level. This ﬁnding is further evidence for the function of the brain-gut
axis. Our technique is also applicable to the investigation of diﬀerent
drugs aﬀecting the central nervous system through the GI tract myo-
electric response. We suppose that this method serves as a good basis
for the development of a new clinical tool to assess the stress and
Fig. 7. Correlation between the changes of the power spectrum density maximum (PsDmax) values in the given sections of the gastrointestinal system (A: stomach, B:
small intestine, C: large intestine) and the changes of corticosterone plasma levels in rats. The linear regression analysis proved a signiﬁcant correlation between
PsDmax and corticosterone alteration.
Fig. 8. Eﬀects of diazepam (A) and haloperidol (B) on KCl induced stomach, ileum and cecum contractions. The change in contraction was calculated via the area
under the curve and expressed in % ± SEM. No signiﬁcant eﬀects were observed directly on the investigated GI samples induced by the drugs.
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anxiety levels of patients in diﬀerent kinds of psychological disorders
and during pharmacotherapy. Our method is the ﬁrst one that can
measure the stress response via the GI tract reactions. This kind of
monitoring of GI tract myoelectric responses may open a new per-
spective in the diagnosis and therapy of psychosomatic disorders.
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